SCHEMBL910291

SCHEMBL910291

CCCCCCCCC/C=C/CCCCCC[C]=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 4/20 0.58
TRPV1 Q8NER1 1/20 0.58
TERT O14746 3/20 0.50
PTPN1 P18031 3/20 0.50
PPARG P37231 3/20 0.50
PPARD Q03181 3/20 0.50
PPARA Q07869 3/20 0.50
TOP1 P11387 3/20 0.50
CYP1A2 P05177 2/20 0.50
MAPT P10636 2/20 0.50
CYP2C19 P33261 2/20 0.50
BLM P54132 2/20 0.50
HSD17B10 Q99714 2/20 0.50
FABP4 P15090 2/20 0.50
KMT2A Q03164 2/20 0.50
GMNN O75496 1/20 0.50
USP2 O75604 1/20 0.50
LMNA P02545 1/20 0.50
POLB P06746 1/20 0.50
CYP2C9 P11712 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8813801 1.00 FAAH (0.58) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL1740121 1.00 FAAH (0.58) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL3413043 1.00 FAAH (0.58) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL1739857 1.00 FAAH (0.58) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL1738577 1.00 FAAH (0.58) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL7300136 1.00 FAAH (0.58) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL38571 1.00 FAAH (0.58) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL3689073 1.00 FAAH (0.58) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL8813806 1.00 FAAH (0.58) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL910387 1.00 FAAH (0.58) FAAHTRPV1TERTPTPN1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7871635-B2 Use of compound that inactivates protein kinase A in a composition containing a cosmetically acceptable medium for lightening the skin SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) 2011-01-18 US claimed
US-20090175811-A1 USE OF COMPOUND THAT INACTIVATES PROTEIN KINASE A IN A COMPOSITION CONTAINING A COSMETICALLY ACCEPTABLE MEDIUM FOR LIGHTENING THE SKIN SOCIETE D'EXPLOITATION DE PRODUCTS LES INDUSTRIES CHIMIQUES SEPPIC (FR) 2009-07-09 US claimed
EP-1927336-A2 Inverse autoinversible latices based on fatty acid esters and cosmetic, dermocosmetic, dermopharmaceutic or pharmaceutic compositions SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES, S.E.P.P.I.C. (FR) 2008-06-04 EP claimed
JP-4074254-B2 2008-04-09 JP claimed
EP-1147765-B1 New active, compositions containing it and it's use in cosmetic, dermocosmetic, dermopharmacy or pharmacy, on woven or nonwoven fabrics SEPPIC SA (FR) 2006-05-03 EP claimed
JP-2005521658-A 2005-07-21 JP claimed
US-20050118119-A1 Use of a compound inactivating the kinase a protein in a composition containg a cosmetically acceptable medium in order to lighten the skin SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES (SEPPIC) (FR) 2005-06-02 US claimed
EP-1471881-A2 USE OF A COMPOUND INACTIVATING THE KINASE A PROTEIN IN A COMPOSITION CONTAINING A COSMETICALLY ACCEPTABLE MEDIUM IN ORDER TO LIGHTEN THE SKIN SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES, S.E.P.P.I.C. (FR) 2004-11-03 EP claimed
WO-2003061768-A2 USE OF A COMPOUND INACTIVATING THE KINASE A PROTEIN IN A COMPOSITION CONTAINING A COSMETICALLY ACCEPTABLE MEDIUM IN ORDER TO LIGHTEN THE SKIN SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES (SEPPIC) (FR) 2003-07-31 WO claimed
US-20020032243-A1 Novel inverse latices self-invertible with respect to fatty acid esters, and cosmetic, dermocosmetic, dermopharmaceutical or pharmaceutical compositions comprising them SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC 2002-03-14 US claimed
US-20020006906-A1 Novel active agent, composition containing it and use in the cosmetic, dermocosmetic, dermopharmaceutical or pharmaceutical field or on woven or nonwoven supports SOCIETE D'EXPLOITATION DE PRODUITS POUR LES 2002-01-17 US claimed
EP-1166771-A1 Invers autoinversible latices based on fatty acid esters and cosmetic, dermocosmetic, dermopharmaceutic or pharmaceutic compositions SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES, S.E.P.P.I.C. (FR) 2002-01-02 EP claimed
EP-1147765-A1 New active, compositions containing it and it's use in cosmetic, dermocosmetic, dermopharmacy or pharmacy, on woven or nonwoven fabrics SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES, S.E.P.P.I.C. (FR) 2001-10-24 EP claimed
US-9005589-B2 Cosmetic composition made from ion-exchange resins filled with lipoaminoacids SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) 2015-04-14 US disclosed
EP-2445477-B1 COSMETIC COMPOSITION MADE FROM ION-EXCHANGE RESINS FILLED WITH LIPOAMINOACIDS SEPPIC SA (FR) 2015-02-11 EP disclosed
EP-2222738-B1 NEW PROCESS FOR THE PREPARATION OF INVERSE LATEX OF ACRYLAMIDE-BASED POLYMERS AND COMPOSITION COMPRISING SAID LATEX SEPPIC SA (FR) 2015-02-11 EP disclosed
US-20020032243-A1 Novel inverse latices self-invertible with respect to fatty acid esters, and cosmetic, dermocosmetic, dermopharmaceutical or pharmaceutical compositions comprising them SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC 2002-03-14 US disclosed
US-20020006906-A1 Novel active agent, composition containing it and use in the cosmetic, dermocosmetic, dermopharmaceutical or pharmaceutical field or on woven or nonwoven supports SOCIETE D'EXPLOITATION DE PRODUITS POUR LES 2002-01-17 US disclosed
EP-1166771-A1 Invers autoinversible latices based on fatty acid esters and cosmetic, dermocosmetic, dermopharmaceutic or pharmaceutic compositions SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES, S.E.P.P.I.C. (FR) 2002-01-02 EP disclosed
EP-1147765-A1 New active, compositions containing it and it's use in cosmetic, dermocosmetic, dermopharmacy or pharmacy, on woven or nonwoven fabrics SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES, S.E.P.P.I.C. (FR) 2001-10-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090175811-A1 USE OF COMPOUND THAT INACTIVATES PROTEIN KINASE A IN A COMPOSITION CONTAINING A COSMETICALLY ACCEPTABLE MEDIUM FOR LIGHTENING THE SKIN PRKACA, PRKACB, PRKACG FAAH 2838/4885TRPV1 2003/4885TERT 2947/4885
US-20020006906-A1 Novel active agent, composition containing it and use in the cosmetic, dermocosmetic, dermopharmaceutical or pharmaceutical field or on woven or nonwoven supports CUTA, PLOD3, SOST FAAH 907/4885TRPV1 203/4885TERT 2928/4885
US-20050118119-A1 Use of a compound inactivating the kinase a protein in a composition containg a cosmetically acceptable medium in order to lighten the skin PRKACG, PRKACA, PRKACB FAAH 3012/4885TRPV1 3208/4885TERT 3736/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.